Last reviewed · How we verify
NCT03789786
Long-term Outcomes of Selective Dorsal Rhizotomy Among Individuals With Cerebral Palsy
trial testing Gait and Motion Analysis in Cerebral Palsy in 78 participants. Completed in 31 January 2020.
31 January 2020
Quick facts
| Lead sponsor | Gillette Children's Specialty Healthcare |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 78 |
| Start date | 1 November 2018 |
| Primary completion | 31 January 2020 |
| Estimated completion | 31 January 2020 |
| Sites | 3 locations across United States |
Drugs / interventions tested
- Gait and Motion Analysis
- Gross Motor Function Measure (GMFM)
- Surveys
Conditions studied
- Cerebral Palsy — all drugs for Cerebral Palsy →
Sponsor
Gillette Children's Specialty Healthcare
Who can join
Adults 21 to 45, any sex, with Cerebral Palsy. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Spasticity affects up to 80% of individuals diagnosed with cerebral palsy. Selective dorsal rhizotomy (SDR) is a surgical method used by some hospitals to permanently reduce spasticity in order to prevent further morbidities. Better understanding of the long-term outcomes of SDR is essential for clinicians and families. The results of this study will have direct clinical impact by equipping providers with the necessary information to counsel families during medical decision making.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Comparing the effects of two spasticity management strategies on the long-term outcomes of individuals with bilateral spastic cerebral palsy: a multicentre cohort study protocol.
Munger ME, Chen BP, MacWilliams BA, McMulkin ML, et al · · 2019 · cited 6× · PMID 31227534 · DOI 10.1136/bmjopen-2018-027486
Verify or expand the search:
- PubMed search for NCT03789786
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Cerebral Palsy
Currently open trials in the same condition.
- NCT07524972 — Antenatal Magnesium Sulphate in High-Risk Preterm Patients · Phase 3 · recruiting
- NCT07432789 — Metrological Properties of a Digital Motion Analysis Research Application for Assessing the Motor Abilities and Performa · NA · recruiting
- NCT07466914 — Constipation in Children With Cerebral Palsy · active not recruiting
- NCT05901259 — The EXOPULSE Study - a Database for Routine Follow-up of Clinical Outcomes · recruiting
- NCT07342348 — Using Power Mobility Training to Promote Arm & Hand Function in Children With Cerebral Palsy · NA · recruiting
Other Gillette Children's Specialty Healthcare trials
Trials by the same sponsor.
- NCT04933448 — Ketogenic Diet Following Moderate to Severe Pediatric Traumatic Brain Injury · NA · completed
- NCT05384951 — HMB Cerebral Palsy Pilot Study · NA · unknown
- NCT03444116 — Long-Term Outcomes of Femoral Derotation Osteotomy for Individuals With Cerebral Palsy · completed
- NCT03135145 — Post-operative Lite Run Study · NA · completed
- NCT03107546 — Comparison of Scar Formation in Syndactyly Release Surgery With Full Thickness Skin Graft Versus Skin Graft Substitute · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03789786 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Gillette Children's Specialty Healthcare
- Last refreshed: 13 October 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03789786.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing